TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $22,045,000 | -21.1% | 1,160,307 | +38.3% | 5.91% | +12.9% |
Q3 2021 | $27,926,000 | +18.2% | 839,128 | +37.8% | 5.24% | +28.2% |
Q2 2021 | $23,628,000 | -19.5% | 609,128 | 0.0% | 4.08% | -23.6% |
Q1 2021 | $29,359,000 | -57.5% | 609,128 | -54.1% | 5.34% | -59.8% |
Q4 2020 | $69,068,000 | +94.4% | 1,327,734 | 0.0% | 13.30% | +70.7% |
Q3 2020 | $35,530,000 | +103.2% | 1,327,734 | +47.9% | 7.79% | +83.7% |
Q2 2020 | $17,489,000 | – | 897,799 | – | 4.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |